Back to REGN
Swedbank AB REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
7
Latest value
$143M
Q3 2026
Peak value
$175.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $175.8M |
| Q4 2025 | $12K |
| Q4 2025 | $175.8M |
| Q4 2025 | $12K |
| Q1 2026 | $166.6M |
| Q2 2026 | $118.4M |
| Q3 2026 | $143M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $143M | 188.6K | — | — |
| Q2 2026 | $118.4M | 189.8K | — | — |
| Q1 2026 | $166.6M | 215.6K | — | — |
| Q4 2025 | $12K | 15 | — | — |
| Q4 2025 | $175.8M | 227.8K | — | — |
| Q4 2025 | $12K | 15 | — | — |
| Q4 2025 | $175.8M | 227.8K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B